The latest news, stories and exciting findings from across the Oxford cancer research community
Yuhan Zheng wins first prize for poster presented at CRUK Oxford Centre Student Symposium.
18 July 2025
Congratulations to Yuhan Zheng (Papiez group, Big Data Institute), who won first prize for their poster ' Advancing Esophageal Cancer Management with Machine Learning: Multicentre Survival Prediction Models and Novel Insights’, presented at this year's CRUK Oxford Centre Student Symposium.
LynchVax Researchers Run Race for Life
19 June 2025
Members of the Oxford Cancer LynchVax group - Aleksandra Dzhoneva and Luciana Gneo - will be running Cancer Research UK's Race for Life this summer to raise money for life-saving cancer research.
Study finds potential path to treatment for an aggressive form of leukaemia
18 June 2025
In a collaborative new study, researchers at Ludwig Cancer Research Oxford have identified a potential new therapeutic target in blast phase myeloproliferative neoplasm, a particularly aggressive and hard-to-treat form of leukaemia.
The stellar mission taking on cellular plasticity in bowel cancer
18 June 2025
Backed by £5.5m of funding from CRUK and its partners, the hugely ambitious CRC-STARS programme - which is co-lead by Professor Simon Leedham in the Nuffeild Department of Medicine - aims to revolutionise how bowel cancer is treated.
Dr Lennard Lee honoured at the national Cancer Vaccines Awards Ceremony
17 June 2025
Dr Lennard Lee, a leading cancer vaccine researcher from the Nuffield Department of Medicine, has been recognised at one of the UK’s most esteemed national oncology gatherings.
Action-packed day of immuno-oncology presentations, PPI and networking at this years' annual OCION Symposium!
16 June 2025
On 13th June 2025 we welcomed 180 members of the Oxford Cancer Immuno-Oncology Network to the Mathematical Institute in Oxford for our annual in-person Symposium.
Oxford Cancer launches 2025 OCION Funding Scheme
13 June 2025
The 2025 Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is now open!
OxCODE funding scheme awards 2025
12 June 2025
Congratulations to Adam Creamer, Pengfei Li, Francisco Lopez-Cuevas, Yuqi Shen and their collaborators who have been awarded funding in the sixth round of the OxCODE Funding Scheme.
New vaccines that aim to prevent cancer: Starting the conversation
11 June 2025
Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.
Celebrating two years of the Oxford Cancer Immuno - Oncology Network
11 June 2025
Professor Tim Elliott, Co- Director of Oxford Cancer, launched the Oxford Cancer Immuno-Oncology Network (OCION) at the inaugural OCION Symposium in June 2023 [pictured]. With our third annual symposium due to take place this month, we look back at some of OCION’s key achievements.
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
Join the Oxford Cancer Celebratory Fun Run!
4 June 2025
Oxford Cancer's Patient and Public Involvement Co-Leads, Sue Duncombe and Patrick McGuire, are undertaking a fundraising challenge for Cancer Research UK and need your help!
Oxford Cancer hosts the inaugural Oxford Liver Cancer Centre of Excellence Symposium
27 May 2025
The first Oxford Liver Cancer Centre of Excellence Symposium took place on Thursday 22nd May in the Richard Doll Building.
Molecule enabling new leukaemia treatments discovered
22 May 2025
Researchers at the Shi Lab have discovered a first-in-class LSD1 PROTAC degrader, which opens up new therapeutic paths for the treatment of acute myeloid leukaemia. PROTAC degraders are molecules that degrade proteins by using the cell’s own machinery, binding to both the target protein and an E3 ligase, which marks it for degradation by the proteasome.
Oxford Cancer shortlisted for Vice-Chancellor’s Award
20 May 2025
The Oxford Cancer Team were finalists in the 'Excellence across Oxford' category at this year's Vice Chancellor's Awards.
Vice-Chancellor's Breakthrough Researcher Award for Dr Joshua Bull
20 May 2025
The University honoured remarkable talent and dedication to excellence on Thursday 15 May as the winners of the Vice-Chancellor's Awards 2025 were announced. Congratulations to Dr Joshua Bull from the Mathematical Institute, who received the Breakthrough Researcher Award.
Professor Andrew McMichael elected to the US National Academy of Sciences
6 May 2025
The National Academy of Sciences (NAS) in the US just announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.
New guidelines published for monitoring IBD patients to prevent bowel cancer
1 May 2025
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Oxford Cancer launches CRIS Cancer Clinical Career Fellow Award 2025
30 April 2025
Together with the CRIS Cancer Foundation, Oxford Cancer has launched the CRIS Cancer Clinical Career Fellow Award 2025, a new opportunity for clinical academics aiming to integrate cancer research with medical practice. Designed to foster independent research careers, this fellowship offers funding of up to £74,600 annually for up to three years to support salaries, research expenses, and clinical activities.
New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes
23 April 2025
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.